Morgan Stanley analyst Adahna Ekoku lowered the firm’s price target on Aperam (APEMY) to EUR 29.60 from EUR 30.10 and keeps an Equal Weight rating on the shares.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APEMY:
- Aperam Reports Challenging Q1 2025 Financial Results
- Aperam’s Strategic Growth and Sustainability Focus in Q1 2025 Earnings Call
- APEMY Upcoming Earnings Report: What to Expect?
- Aperam price target lowered to EUR 38 from EUR 40 at Deutsche Bank
- Aperam downgraded to Neutral from Outperform at Exane BNP Paribas